Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models

Claudio Festuccia(University of L'Aquila), Mauro Bologna(University of L'Aquila)

Endocrine Related Cancer

January 20, 2009

10.1677/erc-08-0130

Cited by 67

Related Papers

The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma

|Journal of Hematology & Oncology|2018|57

The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties

|Frontiers in Pharmacology|2020|28

Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer

|Oncotarget|2017|20